260 related articles for article (PubMed ID: 15628865)
1. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function.
Kapetanaki SM; Chouchane S; Yu S; Zhao X; Magliozzo RS; Schelvis JP
Biochemistry; 2005 Jan; 44(1):243-52. PubMed ID: 15628865
[TBL] [Abstract][Full Text] [Related]
2. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP
Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074
[TBL] [Abstract][Full Text] [Related]
3. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.
Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP
J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090
[TBL] [Abstract][Full Text] [Related]
4. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).
Wengenack NL; Todorovic S; Yu L; Rusnak F
Biochemistry; 1998 Nov; 37(45):15825-34. PubMed ID: 9843388
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding.
Lukat-Rodgers GS; Wengenack NL; Rusnak F; Rodgers KR
Biochemistry; 2001 Jun; 40(24):7149-57. PubMed ID: 11401561
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
[TBL] [Abstract][Full Text] [Related]
7. Impact of distal side water and residue 315 on ligand binding to ferric Mycobacterium tuberculosis catalase-peroxidase (KatG).
Ranguelova K; Suarez J; Metlitsky L; Yu S; Brejt SZ; Brejt SZ; Zhao L; Schelvis JP; Magliozzo RS
Biochemistry; 2008 Nov; 47(47):12583-92. PubMed ID: 18956888
[TBL] [Abstract][Full Text] [Related]
8. Modification of the active site of Mycobacterium tuberculosis KatG after disruption of the Met-Tyr-Trp cross-linked adduct.
Kapetanaki SM; Zhao X; Yu S; Magliozzo RS; Schelvis JP
J Inorg Biochem; 2007 Mar; 101(3):422-33. PubMed ID: 17188362
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant.
Lukat-Rodgers GS; Wengenack NL; Rusnak F; Rodgers KR
Biochemistry; 2000 Aug; 39(32):9984-93. PubMed ID: 10933819
[TBL] [Abstract][Full Text] [Related]
10. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.
Ghiladi RA; Cabelli DE; Ortiz de Montellano PR
J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669
[TBL] [Abstract][Full Text] [Related]
11. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
Yu S; Girotto S; Lee C; Magliozzo RS
J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase.
Zhao X; Yu S; Magliozzo RS
Biochemistry; 2007 Mar; 46(11):3161-70. PubMed ID: 17309235
[TBL] [Abstract][Full Text] [Related]
13. Two [Fe(IV)=O Trp*] intermediates in M. tuberculosis catalase-peroxidase discriminated by multifrequency (9-285 GHz) EPR spectroscopy: reactivity toward isoniazid.
Singh R; Switala J; Loewen PC; Ivancich A
J Am Chem Soc; 2007 Dec; 129(51):15954-63. PubMed ID: 18052167
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.
Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F
J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
[TBL] [Abstract][Full Text] [Related]
16. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.
Saint-Joanis B; Souchon H; Wilming M; Johnsson K; Alzari PM; Cole ST
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):753-60. PubMed ID: 10051449
[TBL] [Abstract][Full Text] [Related]
17. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942.
Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
FEBS J; 2015 Jan; 282(1):54-64. PubMed ID: 25303560
[TBL] [Abstract][Full Text] [Related]
19. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
20. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
